Branded
Legacy, Inc. Innovates with Launch of the First 100% Clear
Kava-Based Vaping Product on the Market
Three
New Products Released Today, With Six More on the
Horizon
Melbourne, FL -- February 6, 2024 -- InvestorsHub NewsWire
-- Branded Legacy, Inc. (OTC.PK:
BLEG), a prominent Biotech company, proudly announces a major
breakthrough in research and development efforts, leading the pack
on new procedures for the extraction and refinement of
kavalactones. In addition, The Alcannabist
LLC, a wholly owned subsidiary of Branded Legacy , announced
the official release of its new line of groundbreaking products
designed to address diverse health and wellness needs.
CEO Dave Oswald had this to say about recent developments in the
lab: "In the past, other companies were only scratching the surface
in their efforts to extract and refine kavalactones. Prior to
our team taking on the challenge of producing a superior product,
the best the market had to offer was a decent purity level with an
inconsistent opaque appearance. We were able to make a high purity
extract that was completely translucent and very flavorful on the
first day. When we presented our extract to our kava
suppliers, they asked to move forward immediately with a white
label contract. Needless to say, we are very excited about
the potential of these developments."
The Alcannabist's new products, which include: VapeRx Anti
Anxiety, ElixRx Migraine/Headache Support, and Mood Mix Capsules,
are now officially on the market. This marks a significant
expansion of The Alcannabist's product offerings. Three of
their six new products, (VapeRx Plus Kava Anti Anxiety Rescue,
VapeRx Plus Kava Sleep, and VapeRx Plus Kava Pain
Management), will be added to their VapeRx line in the coming
weeks. The other three, ElixRx Plus Kava Anti Anxiety, ElixRx Plus
Kava Sleep, and ElixRx Plus Kava Pain Management, will be included
in their ElixRx line. These products will be the first of
many additions to their soon to be released Kava Plus family of
therapeutics.
Joseph Holladay, Chief Operating Officer of Branded Legacy, and
one of the principal developers of these products, expressed
excitement about the new Kava Plus product lineup, stating, "Our
team is dedicated to developing innovative solutions that cater to
diverse wellness needs. These new Kava Plus products represent a
significant step forward in our commitment to providing effective
and accessible options for our customers. The Kava Plus line
is one that I'm particularly excited about. We had great feedback
on our CBD based sleep, pain and anxiety products, but we feel the
addition of Kava has the ability to supercharge them for many of
our customers, and the response we've gotten so far has
surpassed our expectations."
Newly Released Products:
VapeRx Anti Anxiety Rescue: A revolutionary CBD
vape, carefully crafted to provide relief from anxiety. This
product leverages the calming properties of CBD and scientifically
derived combination of terpenes to offer users a soothing and calm
state of mind.
ElixRx Migraine: Specifically formulated to
address headaches and migraines, ElixRx Migraine offers targeted
relief with a proprietary blend of terpenes and cannabinoids
designed to alleviate all types of headaches.
Mood Mix Capsules: Mood Mix introduces a
mitragynine product in convenient 25ml powder capsules, offering
users a unique and controlled way to incorporate this botanical
substance into their wellness routines. Mood Mix is formulated to
improve mood, alleviate pain, and provide a sustained energy
boost.
Upcoming Product Releases:
VapeRx Plus Kava Anti Anxiety Rescue, VapeRx Plus Kava
Sleep, and VapeRx Plus Kava Pain Management: Soon to be
launched, these vapable CBD plus Kava products aim to enhance the
anti-anxiety effects, promote restful sleep, and manage pain
effectively.
ElixRx Plus Kava Anti Anxiety, ElixRx Plus Kava Sleep,
and ElixRx Plus Kava Pain Management: Expected to be
available shortly, these ElixRx Plus Kava products will offer a
comprehensive and sustained approach to anti-anxiety, sleep aid,
and pain management.
Branded Legacy remains at the forefront of the industry,
continually pushing the boundaries of CBD and botanical-based
products. With a focus on quality, safety, and efficacy, the
company strives to make a positive impact on its customers,
employees, and shareholders. In a proactive move to strengthen the
company's financial position and enhance shareholder value, Branded
Legacy, Inc. recently negotiated the purchase of outstanding debt
of $1,500,000 at a remarkable price of $450,000. This strategic
decision not only eliminates a substantial liability but also
safeguards against any potential conversion of the debt into
shares. With a commitment to fiscal responsibility, a
relentless pursuit of useful alkaloids, and a dedicated product
development team, stay tuned for the continued release of many
outstanding products.
For media inquiries, please contact:
Investor Relations & Media Contact
Joe Holladay
Branded Legacy
Phone: 321-345-3565
Email: info@brandedlegacy.com
Website: https://brandedlegacy.com/
About Branded Legacy, Inc.:
Branded Legacy, Inc. (OTC: BLEG) is a diversified holdings
company focused on the biotech sector. With a commitment to
excellence and innovation, Branded Legacy specializes in the
development and marketing of cutting-edge products and services.
The company's diverse portfolio includes ventures in biotechnology,
digital solutions, and wellness products, all aimed at enhancing
the quality of life for its customers. Branded Legacy's strategic
approach to growth involves identifying and integrating promising
businesses and technologies that align with its mission to deliver
sustainable, high-quality products and services.
Safe Harbor Statement on Forward-Looking Language:
This release includes forward-looking statements, which are
based on certain assumptions and reflect management's current
expectations. These forward-looking statements are subject to a
number of risks and uncertainties that could cause actual results
or events to differ materially from current expectations. Some of
these factors include general global economic conditions; general
industry and market conditions and growth rates; uncertainty as to
whether our strategies and business plans will yield the expected
benefits; increasing competition; availability and cost of capital;
the ability to identify and develop and achieve commercial success;
the level of expenditures necessary to maintain and improve the
quality of services; changes in the economy; changes in laws and
regulations, includes codes and standards, intellectual property
rights, and tax matters; or other matters not anticipated; our
ability to secure and maintain strategic relationships and
distribution agreements. Dilution, if any, would be for the
purposes of management taking stock in lieu of cash salary. The
company disclaims any intention or obligation to update or revise
any forward-looking statements, whether as a result of new
information, future events, or otherwise. Additionally, this press
release that is not statements of historical fact may be considered
to be forward-looking statements. Written words such as "may,"
"will," "expect," "believe," "anticipate," "estimate," "intends,"
"goal," "objective," "seek," "attempt," or variations of these or
similar words, identify forward-looking statements. By their
nature, forward-looking statements and forecasts involve risks and
uncertainties because they relate to events and depend on
circumstances that will occur in the near future.